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Transcriptional Coactivator, CIITA,
Is an Acetyltransferase that Bypasses
a Promoter Requirement for TAFII250
histones, whose acetylation results in relaxation of chro-
matin structure, allowing easier access to the promoter
by the transcriptional machinery (Ogryzko et al., 1996;
Yang et al., 1996; Mizzen et al., 1996). The other set
of substrates consists of various transcription factors,
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such as p53, HMG-1, and GATA-1 (Gu and Roeder, 1997;National Cancer Institute
Boyes et al., 1998), whose acetylation can alter theirBuilding 10, Room 4B-36
DNA binding affinity, and HNF-4, which has enhancedNational Institutes of Health
nuclear localization upon acetylation (Soutoglou et al.,Bethesda, Maryland 20892
2000).†Lineberger Cancer Center
Many of the best-characterized coactivators studiedUniversity of North Carolina
are constitutively expressed in most cell types. In con-Chapel Hill, North Carolina 27599
trast, the coactivator CIITA is tissue-specific and induc-‡Riken Life Sciences
ible (Fontes et al., 1996). CIITA is constitutively ex-Tsukuba
pressed in B lymphocytes and other professionalJapan
antigen presenting cells, but can be induced in other
cell types in response to g-IFN (Chin et al., 1994; Steimle
et al., 1994). CIITA forms part of the transcription com-Summary
plex that is necessary for de novo expression of MHC
class II genes (Riley et al., 1995; Zhou and Glimcher,The CIITA coactivator is essential for transcriptional
1995) and to enhance constitutive expression of MHCactivation of MHC class II genes and mediates en-
class I genes (Gobin et al., 1997; Martin et al., 1997).hanced MHC class I transcription. We now report that
The absence of CIITA leads to complete loss of MHCCIITA contains an intrinsic acetyltransferase (AT) ac-
class II and markedly reduced MHC class I expression.tivity that maps to a region within the N-terminal seg-
CIITA restores expression of both sets of moleculesment of CIITA, between amino acids 94 and 132. The
(Chang et al., 1994; Martin et al., 1997). Because theAT activity is regulated by the C-terminal GTP-binding
products of both MHC class I and class II genes aredomain and is stimulated by GTP. CIITA-mediated
involved in the initiation and propagation of immunetransactivation depends on the AT activity. Further,
responses, defects in CIITA expression result in pro-we report that, although constitutive MHC class I tran-
found immunodeficiencies (Steimle et al., 1993; Changscription depends on TAFII250, CIITA activates the pro-
et al., 1996).moter in the absence of functional TAFII250.
CIITA is a protein of 135 kDa, consisting of 1220 amino
acids. Molecular characterization of CIITA has identifiedIntroduction
a series of regulatory domains: an a-helical activation
domain, and a proline/serine/threonine (PST) activationTranscription of RNA polymerase II-dependent promot-
domain in the first 300 N-terminal amino acids (Chiners is mediated by sequence-specific transcription fac-
et al., 1997). A GTP-binding domain, located betweentors that bind to upstream regulatory elements and
amino acids 421 and 561, regulates nuclear localizationrecruit general transcription factors (GTFs) to the down-
of CIITA (Harton et al., 1999). Typical of coactivators,stream core promoter (Sauer et al., 1995; Orphanides
CIITA does not bind DNA directly (Steimle et al., 1993).
et al., 1996; Wang et al., 1997; Carey, 1998; Li et al.,
Rather, it interacts with DNA binding transcription fac-
1999). In many cases, this interaction is facilitated by
tors such as RFX (Scholl et al., 1997), basal transcription
non-DNA binding coactivators (Merika et al., 1998; factors such as hTAFII32, hTAFII70, TFIIB, (Fontes et al.,Hampsey and Reinberg, 1999; Xu et al., 1999). Coacti- 1997; Mahanta et al., 1997; Scholl et al., 1997), and the
vators are generally large proteins with multiple binding coactivator CBP (Kretsovali et al., 1998; Fontes et al.,
sites for both DNA binding transcriptional activators and 1999).
GTFs (Barlev et al., 1995; Cho et al., 1998). Their function Transcription initiation requires the assembly of a
is, in part, to link upstream activators and repressors complex consisting of general transcription factors and
with downstream basal transcription machinery, inte- RNA polymerase II (Roeder, 1996; Verrijzer and Tjian,
grating regulatory signals (Chen et al., 1994; Harrod et 1996). It is generally thought that the initiating event is
al., 2000). Coactivators often possess one or more ac- the binding of the general transcription factor TFIID to
tivities, which contribute to transcriptional activation the core promoter (Klages and Strubin, 1995; Komarnit-
(Krumm et al., 1998). One common feature of many co- sky et al., 1998). TFIID is a multi-protein structure con-
activators is the presence of acetyltransferase (AT) ac- sisting of the TATA binding protein (TBP) and a series
tivity (Davie, 1998). Two functions have been ascribed of TBP-associated factors (TAFs), including TAFII250 (Hi-
to the AT activity of coactivators based upon their target satake et al., 1993; Weinzierl et al., 1993). Although early
substrates. One set of AT substrates is nucleosomal studies suggested that a fully assembled TFIID was nec-
essary for proper transcription initiation (Chen et al.,
1994), recent evidence suggests that the TAF require-§ To whom correspondence should be addressed (email: dinah.
singer@nih.gov). ments vary among different promoters (Moqtaderi et al.,
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1996; Walker et al., 1996; Metzger et al., 1999; Kuras et
al., 2000; Li et al., 2000). Indeed, in previous studies, we
have demonstrated that transcription of MHC class I
genes requires TAFII250 (Weissman et al., 1998). Further,
regulation of class I expression was correlated with
TAFII250 AT activity. Thus, temperature sensitive abla-
tion of TAFII250 AT activity prevented class I transcrip-
tion (Weissman et al., 1998). However, class I expression
was restored when a strong viral enhancer was inserted
upstream of the class I promoter (Weissman et al., 2000).
This led to the suggestion that upstream activators
could modulate the dependence on TAFs of a given
promoter.
We now report that the coactivator CIITA contains
acetyltransferase activity, which maps to its N terminus
and which is modulated by the C-terminal GTP-binding
domain and enhanced by GTP. The AT domain is neces-
sary for activation of both class I and class II transcrip-
tion. Furthermore, and of particular interest, although
constitutive MHC class I transcription requires TAFII250,
CIITA-mediated activation does not; the AT domain of
CIITA is necessary for this activity. We propose a model
for dynamic modulation of core promoter requirements
mediated by CIITA.
Results
An Acetyltransferase Activity Is Associated with CIITA
The coactivator properties of CIITA led us to speculate
that CIITA might function as an acetyltransferase, analo-
gous to other coactivators. CIITA immunoprecipitated
from transfected HeLa cells was assayed for AT activity
using histones H3/H4 as substrates for acetylation. As
shown in Figure 1, immunoprecipitates from CIITA trans-
fected cells, but not from control cells, acetylated his-
tones. No autoacetylation of CIITA was detected. West-
ern blot analysis identified a protein with a molecular
weight corresponding to that of CIITA (135 KD), demon-
strating the presence of CIITA (Figure 1A). These data
demonstrate that an AT activity is associated with CIITA.
Other known AT-containing proteins, such as TAFII250, Figure 1. AT Activity Coimmunoprecipitates with CIITA
p300 and PCAF, did not coimmunoprecipitate with
(A) Western blot of CIITA immunoprecipitated from transfected HeLaCIITA, as detected by Western blot analysis (data not
cells (right), or rCIITA purified from Sf9 cells (left). Immunoblot of
shown). Furthermore, recombinant CIITA (rCIITA) puri- total lysate, anti-Flag immunoprecipitate (IP), and the depleted su-
fied from Sf9 cells displayed AT activity (Figure 1), pernatant of CIITA or control vector transfected cells.
(B and C) CIITA immunoprecipitate contains AT activity. Anti-Flag-whereas control extract did not. Taken together, these
CIITA immunoprecipitates from CIITA, or control transfected HeLadata indicate that the AT activity is intrinsic to the CIITA
cells (B), or purified recombinant CIITA (50 ng) (C) were assayed forprotein.
AT activity, which was quantitated by phosphorimager and cor-
rected for protein. The insets show phosphorimager profile of acet-
Mapping of AT Domain in CIITA ylated histones.
To map the AT domain, we generated a C-terminal trun-
cation mutant of CIITA, which terminated at 802 aa
(CIITADC, Figure 2A). This mutant was expressed in (CIITADST) did not (Chin et al., 1997). All three of these
deletion mutants retained AT activity (Figure 2 and datatransfected HeLa cells at levels comparable to wild-type
CIITA (data not shown). Importantly, it retained full AT not shown); thus, the region 132–301 does not encom-
pass the entire AT domain. However, the deletion span-activity (Figure 2B), demonstrating that the AT domain
resides within the N terminus of CIITA. Previous analyses ning the P domain, (CIITADP) reduced the AT activity
(Figure 2A). Immunoblots confirmed that the deletionof CIITA activation domains have identified a proline,
serine, threonine rich region (PST domain) between mutants are expressed at equivalent levels and are of
the expected molecular weight (data not shown). Takenamino acids 132 and 301; removal of the entire PST
domain (CIITADPST) eliminated CIITA transactivation, together, these data indicate that the AT domain resides
N terminal to the proline domain, but may partially over-but deletion of either the proline domain 132–209
(CIITADP) or the serine/threonine domain 209–301 lap it.
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Figure 2. Mapping of the AT Domain of CIITA
(A) Flag-tagged CIITA constructs, as schema-
tized, were immunoprecipitated from HeLa
cells or Sf9 cells and assayed for AT activity;
AT activity of CIITA mutants relative to CIITA
WT is shown. The effect of 1.25 mM GTP on
relative activity of rCIITA is shown in the third
column.
(B) Sequence alignment of CIITA AT domain
with CBP HAT domain. Star indicates same
or related amino acid residues.
(C) CIITAD942135 does not activate MHC
class I or class II promoters. HeLa cells were
cotransfected with 2 mg of CIITA WT, mutant
CIITA or control vector, and 5 mg of either
2416CAT class I reporter construct (left) or
DRa CAT class II reporter construct (right).
Data are normalized to transfection control
pSV2LUC.
To further map the location of the AT domain, we CIITA AT Domain Is Homologous
to the CBP AT Domainexamined the AT activities of additional mutants. The
first mutant contained an internal deletion of the region A homology search of the CIITA AT domain revealed a
striking similarity to the known AT domain of CBP (Figurebetween 27 to 222 aa (CIITAD27–222) (Figure 2A). This
mutant was expressed at levels similar to wild-type 2B). Between residues 116 and 120 of CIITA there is
complete identity with the CBP AT domain. Further shortCIITA and readily immunoprecipitated (data not shown).
However, no AT activity was associated with CIITAD27– stretches of homology with CBP are observed between
aa 102 and 123. No homologies with other known co-222 (Figure 2). Since the CIITADP mutant (132–209) re-
tains AT activity, these results taken together map the activators with AT activity, i.e., TAFII250, P/CAF, GCN5
and p300, were found. The AT domain of CIITA doesAT domain between amino acids 27 and 132. A mutant
with a small deletion, extending between amino acids not correspond to any previously defined structural or
functional domain. In particular, it is distinct from the94 and 135, also had no AT activity, further refining
the essential AT domain to a segment between 94–132 three predicted a helices identified by Peterlin (Fontes
et al., 1997). From this analysis, we propose that theamino acids (Figure 2).
To directly demonstrate the presence of AT activity segment 102–123 of CIITA is contained within the AT
domain.within the N terminus of CIITA, we examined a C-terminal
truncation construct encoding amino acids 1 to 148
(CIITA 1–148). CIITA 1–148 displayed significantly higher CIITA AT Activity Is Modulated
by Its GTP-Binding DomainAT activity than wild-type CIITA (Figure 2), suggesting
that there are certain regions in the full-length CIITA that The above studies demonstrated that the N-terminal
region of CIITA is necessary for AT activity, but did notnegatively regulate the AT activity. These data confirm
the presence of an AT domain within the first 148 amino exclude the participation of other domains in regulating
the AT activity. One region that potentially could affectacids, and, taken together with the deletion mapping,
localizes it to the segment 94–132 aa. CIITA AT activity is the tri-partite GTP-binding domain
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between amino acids 421 and 561 that has been shown isolated from CBP-deficient cells following transfection
was indistinguishable from the control (Figure 3A), dem-to play a role both in transactivation and nuclear localiza-
tion (Chin et al., 1997; Harton et al., 1999). Therefore, we onstrating that the AT activity of CIITA is not dependent
on CBP. Importantly, cotransfection of CIITA and thenext asked whether CIITA mutants with crippled GTP-
binding domains retain AT activity. Three CIITA mutant class I promoter into the CBP-deficient cells resulted in
activation of the promoter (Figure 3B). Taken together,proteins, with substitutions in either the phosphate
(K→E, DKG) or guanine-binding domains (DSKAD) were the above experiments demonstrate that CBP is not
necessary for CIITA-mediated activation of the class Iimmunoprecipitated from transfected HeLa cells and
tested for AT activity (Figure 2). All three retained AT promoter or for its AT activity.
activity. Thus, AT activity is not completely dependent
on the GTP-binding domain. However, each of the mu- CIITA Activates MHC Class I Transcription through
tants displayed reduced AT activity relative to wild-type a Series of Upstream Regulatory Elements
CIITA; recombinant K→E and DSKAD mutant proteins MHC class I transcription is regulated by a series of
purified from Sf9 cells showed a similar reduction in regulatory elements that extend 1 kB upstream of tran-
activity (Figure 2). Furthermore, addition of GTP to the scription initiation (Maguire et al., 1992). To determine
AT assay reproducibly and significantly stimulated AT which elements are targeted by CIITA, activation of a
activity of wild-type CIITA (2.1 6 0.05 fold), whereas it series of promoter deletion mutants by CIITA was exam-
had no effect on the DSKAD mutant. These findings ined. As shown in Figure 4A, CIITA stimulated the activity
indicate that the C-terminal GTP domain modulates the of the longest (21100 bp) promoter construct by z15-
N-terminal AT activity of CIITA. fold. Successive 59 truncation of upstream sequences
resulted in reduced, but significant levels of CIITA-medi-
ated activation. 2- to 3-fold activation was still observedCIITA AT Domain Is Required for Coactivation
Since CIITA is a coactivator of MHC class I and II gene in a promoter construct containing only 135 bp of flank-
ing sequences. However, further truncation to 68 bptranscription, the functional requirement for its AT do-
main was assessed. A CIITA expression plasmid was generated a construct that retained substantial constitu-
tive promoter activity but completely failed to be trans-cotransfected into HeLa cells with a class I promoter
construct consisting of 416 bp of upstream promoter activated by CIITA. These data demonstrate that an ele-
ment located between 2135 bp and 268 bp is necessarysequences, ligated to the CAT reporter. CIITA activation
was determined by comparison with a control transfec- for CIITA transactivation, and that a series of upstream
elements influences the extent of activation by CIITA.tion using an empty expression vector. As previously
described, class I transcription was increased z3 fold We next examined the target element(s) for CIITA in
the 268 to 2135 segment of the class I promoter. Thein the presence of wild-type CIITA (Figure 2C). In con-
trast, the CIITAD94–135 construct, which has no AT ac- interval between 2135 bp and 268 bp contains a CRE,
which has been shown to be the target of cAMP-medi-tivity but retains the PST activation domain, was unable
to transactivate the class I promoter (Figure 2C, left- ated repression of class I transcription (Saji et al., 1997;
Kirshner et al., 2000). Therefore, we determined the re-hand panel). However, the CIITADP construct, which
retains AT activity, was capable of fully transactivating sponse to CIITA of class I promoter constructs con-
sisting of 209 bp of upstream sequences that had beenthe class I promoter (data not shown and Figure 5). Thus,
a CIITA segment necessary for transactivation maps to deleted of either the CRE element (2100 to 2107) or
an upstream 30 bp enhancer element (2127 to 2168)the region 94–132 aa, coincident with the AT domain.
Deletion of CIITA AT domain also abrogated MHC class (Figure 4B). Whereas the wild-type 2209 bp-construct
was activated z5-fold by CIITA, CIITA had no effect onII DRa promoter activity (Figure 2C, right-hand panel).
These experiments indicate that the CIITA-associated the basal activity of the 2209 construct deleted of the
CRE (Figure 4B, 2209DCRE). Similarly, a promoter con-AT activity is necessary for transactivation of both the
class I and class II promoters. struct in which the CRE was mutated, rather than de-
leted, was also refractory to CIITA transactivation (Fig-
ure 4B, 2209NPCRE). In contrast, deletion of the 30-merCIITA Activity Does Not Require Participation of CBP
element reduced, but did not eliminate CIITA-mediatedCIITA is known to bind to CBP; this interaction results
activation (Figure 4B, 2209D30). Since this latter dele-in synergistic activation of MHC class II genes (Kretso-
tion also eliminates the interferon response elementvali et al., 1998; Fontes et al., 1999). However, CBP alone
(IRE), CIITA activation of class I does not require thedoes not contribute to constitutive class I promoter ac-
IRE. In support of these conclusions, the isolated CREtivity (Kirshner, Weissman and Singer, unpublished;
element but not the IRE element, was able to conferFontes et al., 1999). Therefore, we next examined
CIITA responsiveness on a heterologous viral promoterwhether CBP participates in CIITA-mediated activation
which is not normally activated by CIITA (Figure 4C).of class I promoter activity. The effect of CIITA on class
Thus, the class I CRE is necessary for CIITA-mediatedI promoter activity was assessed in cells deficient in
activation.CBP. A CBP-deficient cell line was generated by stably
transforming mouse L cells with a ribozyme vector that
inactivates CBP transcripts (Kawasaki et al., 1996; Ka- CIITA Activation of the Class I Promoter
Does Not Depend upon a Specific Corewasaki et al., 1998). As shown in Figure 3A (inset), levels
of CBP in these cell lines were 20% or less than in L Promoter Element
The MHC class I core promoter spans 50 bp and con-cells stably transformed with a mutated CBP ribozyme
construct. Nevertheless, the level of AT activity of CIITA tains a variant TATAA box (TCTAA), an Inr and an essen-
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Figure 3. CBP Is Not Required for CIITA-Mediated Activation of the Class I Promoter
(A) L cells (CBP2) and (CBP1), stably transformed with CBP ribozyme or mutant CBP ribozyme respectively, and control L cells were
transfected with 10 mg of Flag-CIITA. Flag-CIITA was captured from lysates on anti-Flag M2 agarose beads and assayed for AT activity.
Histone acetylation was corrected for input protein concentration. The inset shows anti-CBP Western blot of stably transformed L cell lysate.
(B) L cells (CBP2) and (CBP1), stably transformed with CBP ribozyme or mutant CBP ribozyme, respectively, and control L cells were
cotransfected with 5 mg of 2416 CAT and 2 mg of either CIITA (closed bar) or control vector pcDNA3 (open bar). CAT activity was assayed
after 48 hr. Data are normalized to transfection control, pSV2LUC.
tial S box element located between the TCTAA and Inr class I transcription requires the AT activity of the TFIID
component, TAFII250 (Weissman et al., 1998). Sincesequences (Howcroft et al., 1995). The question of
whether CIITA requires a specific core promoter element CIITA interacts with the TFIID component TAFII32
(Fontes et al., 1997) and appears to target the transcrip-has not been addressed previously. Therefore, we ex-
amined the ability of CIITA to activate class I reporter tion initiation complex (Mahanta et al., 1997), we consid-
constructs containing mutations within the core pro- ered the possibility that CIITA activation could bypass
moter (Figure 4D). We have shown previously that muta- the TAFII250 requirement of constitutive class I tran-
tions of either the TCTAA element (416TM1) or the Inr scription.
(416M3) reduced, but did not eliminate, constitutive pro- This possibility was tested in the hamster cell line
moter activity in the absence of CIITA (Howcroft et al., tsBN462, which contains a temperature-sensitive muta-
1995). Indeed, a promoter construct (416M5) in which tion in TAFII250 (Hayashida et al., 1994). In tsBN462 cells
both promoter elements have been mutated was consti- at the permissive temperature (328C), TAFII250 is func-
tutively active (Howcroft et al., 1995). All three promoter tional and the class I promoter is active; at the restrictive
mutants were activated by CIITA; the extent of activation temperature (398C), TAFII250 loses AT activity and is
was similar to wild-type promoter (Figure 4D). However, inactive (Dunphy et al., 2000); basal transcription of the
CIITA did not activate a mutant in which the entire core class I promoter is impaired (Weissman et al., 1998).
promoter region was deleted (416DKH). These data Cotransfection of CIITA with the class I promoter con-
demonstrate that CIITA activation requires a promoter, struct, 2416CAT, into tsBN462 cells at the permissive
but does not depend upon a specific promoter element. temperature resulted in activation of the promoter (Table
Surprisingly, CIITA was able to activate transcription 2A). Surprisingly, when the transfected cells were shifted
from a promoter mutant that displays no constitutive to the restrictive temperature (398C), CIITA restored
activity. Mutation of the 17 bp S box located between the class I promoter activity (Table 2A). Thus, CIITA could
TCTAA and Inr elements (416M6) results in a promoter bypass the TAFII250 requirement. The MHC class II re-
inactive in constitutive expression (Table 1). However, porter construct DRaCAT was also activated by CIITA
in the presence of CIITA, 416M6 was active. In contrast, at both restrictive (328C) and permissive (398C) tempera-
the promoter-less control, pSV0, displayed neither tures in tsBN462 cells (Table 2B), further demonstrat-
constitutive activity nor response to CIITA. Thus, the ing that CIITA-mediated activation is independent of
promoter element requirements for CIITA-mediated TAFII250.
transcription are distinct from those of constitutive tran- As shown above, a CRE element in the class I pro-
scription. moter was critical for CIITA activation. We next exam-
ined whether the requirements for CIITA-mediated acti-
vation are similar in the presence and absence ofCIITA Bypasses the Promoter Requirement
TAFII250. The 2416CAT and 2135CAT constructs,for TAFII250
which contain the CRE, were both activated by CIITAThe above data demonstrate that CIITA has AT activity
at both the permissive and restrictive temperatures.and that the AT domain is necessary for transcriptional
activation. We have shown previously that constitutive However, 268CAT, which does not contain the CRE, no
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Figure 4. MHC Class I Core and Upstream Regulatory Elements Required for CIITA-Activated Transactivation
HeLa cells were cotransfected with 5 mg of different truncation deletions of MHC class I extended promoter, as shown on left side of each
panel, and 2 mg of CIITA (closed bar) or the control vector (open bar). After 48 hr, the promoter activity was studied by CAT assay, normalized
to transfection control pSV2LUC. Shown is CAT activity relative to the control vector.
(A) CIITA activates MHC class I transcription through a series of upstream regulatory elements. The 268CAT construct, in the absence of
CIITA, is 19.8 6 2.5 more active than a negative control. The relative activities of the deletion series, in the absence of CIITA, are: 21100CAT,
1.32 6 0.4; 2513CAT, 3.1 6 1.7; 2416CAT, 10.3 6 6.3; 2313CAT, 7.1 6 5.4; 2209CAT, 4.3 6 1.9; 2135CAT, 3.8 6 1.9; 268CAT, 1. The data
presented are the compilation of 5 separate experiments. EnhA, enhancer A; IRE, interferon response element; CRE, cAMP response element.
(B) CIITA activates MHC class I transcription through the class I CRE. NPCRE, non-palindromic mutant CRE.
(C) CIITA activates the heterologous SV40 promoter in the presence of an upstream class I CRE.
(D) Target of CIITA activation of class I does not depend on a single promoter element. Mutated promoter elements are indicated by a solid
rectangle. All data are presented as activity in the presence of CIITA, relative to the absence of CIITA.
longer responded to CIITA activation at either tempera- CIITA Activation in the Absence of TAFII250
Depends on Its AT Activityture (Table 2A and B). Activation of class I promoter at
the restrictive temperature was found to be specific for We next determined which CIITA domain(s) were re-
quired to activate class I expression in tsBN462 cellsCIITA, since neither p300 nor CBP, two coactivators
known to have acetyltransferase activity, activated (Ta- at the restrictive temperature. CIITA deletion mutants
lacking AT activity (D95–135 and D27–222), unlike wild-ble 2C).
type CIITA, were unable to restore class I promoter activ-
ity at the restrictive temperature (Table 2D). Thus, AT
Table 1. CIITA Overcomes a Class I Promoter Defect activity is necessary for promoter activation by CIITA in
Construct Control CIITA Fold Activation the presence and absence of TAFII250 activity. In
tsBN462 cells at 328C, partial deletions of the PST do-2416WT 55.3 6 3.2 381.2 6 17.4 6.7
mains (CIITADP or CIITADST9) partially reduced activa-2416M6 6.1 6 0.2 144.2 6 4.0 23.6
pSV0 8.3 6 0.1 12.0 6 0.7 1.4 tion of the class I promoter, whereas a complete deletion
(CIITADPST) completely abrogated the coactivationHela cells were cotransfected with 5 mg of MHC class I reporter
function (Figure 5A); none of these deletions abrogatedconstructs 2416 WT, 2416M6, or the promoterless pSV0 control
and 2 mg of either CIITA or the control vector. CAT activity was AT activity. Promoter activation by CIITA at 39.58C
assessed after 48 hrs, and normalized to transfection control, shows parallel requirements for the PST domain: partial
pSV2LUC. Shown is CAT activity in absence and presence of CIITA deletions provided only partial rescue, and the complete
and the fold activation.
deletion was unable to rescue at all (Figure 5A). These
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Table 2. CIITA Activation of the Class 1 Promoter Does Not Require TAFII250
A. CIITA Activates class I and class II transcription at the restrictive temperature in tsBN462 cells
Construct Temp. Control CIITA
2416CAT 328C 11.6 6 0.6 34.4 6 1.4
398C 3.6 6 0.2 18.3 6 1.2
DRa CAT 328C 6.6 6 0.4 62.0 6 2.9
398C 3.0 58.3 6 3.2
B. CIITA activation of the class I promoter in tsBN462 cells requires the CRE
Construct Temp. Control CIITA
2135CAT 328C 21.7 6 1.8 44.5 6 2.1
398C 1.9 6 0.2 16.7 6 0.5
268CAT 328C 33.9 6 1.4 23.5 6 1.1
398C 3.0 6 0.7 1.8 6 0.2
C. CBP and p300 do not activate the class I promoter
Relative Activity
Construct 328C 39.58C (398C/328C)
Control 6.3 0.84 0.13
p300 9.1 0.66 0.07
CBP 7.5 1.34 0.18
D. CIITA activation of the class I promoter in the absence of TAFII250 depends on its AT domain
Relative Activity
Promoter construct CIITA Construct (398C/328C)
2313CAT(class I) Control 0.18 6 0.02
CIITA WT 0.50 6 0.03
CIITAD94–135 0.11 6 0.01
CIITAD27–222 0.12 6 0.01
2 mg of CIITA WT or CIITAD94–135 and CIITAD27–222 (A, B and D) or 3 mg of p300 or CBP (C) with appropriate vector controls were
cotransfected with 5 mg of class I CAT or pSV2 CAT reporter construct, in tsBN462 cells at 328C. After 24 hrs cells were shifted to 398C or
left at 328C for an additional 24 hrs before harvesting and performing CAT assay. In A and B data are expressed as percentage of acetylation
at permissive (398C) or restrictive temperature (328C) normalized to transfection control. Data in C and D are expressed as relative promoter
activity which is the ratio of the activity of a given promoter at the two temperatures.
experiments demonstrate that the PST activation do- MHC class I genes (Martin et al., 1997; van den Elsen
main is necessary for promoter activation in the absence et al., 1998a, 1998b). In the present study, we have
of functional TAFII250. Thus, although activation requires demonstrated that CIITA has intrinsic acetyltransferase
the AT domain of CIITA, other domains are also nec- (AT) activity and have mapped the AT domain to the N
essary. terminus of CIITA between 94–132 aa. Deletion of this
Interestingly, mutations within the GTP-binding do- segment of CIITA results in a loss both of AT activity
main reveal that the requirements for CIITA coactivation and of transactivation of class I and class II promoters.
in the presence and absence of TAFII250 are separable Although the AT domain is necessary for CIITA trans-
activities within the CIITA molecule. Thus, mutation of activation, it alone is not sufficient. GTP stimulates AT
the phosphate-binding region (K→E, DKG) did not mark- activity and this stimulation is dependent upon the GTP-
edly affect CIITA activation at 328C, but completely elimi- binding domain. The GTP-binding domain has multiple
nated it at 39.58C (Figure 5B). Although these mutants functions: it modulates the AT activity and is also re-
have reduced nuclear transport, this cannot account for quired for nuclear localization and dimerization of CIITA
the differential effect (Harton et al., 1999). In contrast, (Ting et al., in preparation). Dimerization may require
mutation of the guanine-binding segment (DSKAD) elimi- GTP and be necessary to achieve maximal levels of acet-
nated both activities. Taken together, these data sug- ylation. Other AT containing coactivators are known
gest that activation in the presence and absence of to dimerize. PCAF, which has intrinsic AT activity, was
TAFII250 largely depends on the same molecular do- originally isolated in a complex with CBP/p300 (Yang et
mains, but the activities are separable and have distinct al., 1996). It is interesting to speculate that the extent
requirements. of acetylation, and pattern of acetylation of the sub-
strate, is determined by the interactions of different AT
proteins. Previous analyses of CIITA structure haveDiscussion
identified additional activation domains: an N-terminal
acidic domain, a ProSerThr domain, a GTP-binding do-CIITA is a coactivator necessary for both the induction
main, and a C-terminal domain (Riley et al., 1995; Zhouof de novo MHC class II gene transcription and the
enhanced expression of the constitutively transcribed and Glimcher, 1995; Chin et al., 1997). The N-terminal
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sponds to the CRE.) that is required for MHC class I
activation by CIITA (Gobin et al., 1997; Martin et al.,
1997). Taken together, our findings demonstrate that
the class I CRE functions as a context-dependent tran-
scriptional regulatory element.
An important new observation to emerge from the
present studies is that the DNA sequence requirements
for CIITA-mediated activation of transcription are dis-
tinct from those of constitutive transcription. Constitu-
tive transcription, in the absence of CIITA, depends upon
a promoter element located between the TATAA and Inr
elements of the class I promoter, the S box sequence
(Howcroft et al., 1995). A promoter construct mutated in
this region (416M6) is completely inactive in constitutive
transcription (Howcroft et al., 1995). However, in the
presence of CIITA, the same promoter construct is fully
active. Furthermore, although CIITA-mediated activa-
tion requires a core promoter, no specific sequence
element is targeted. This suggests that CIITA activates
transcription by a mechanism distinct from that of con-
stitutive transcription.
This interpretation is supported by the observation
that the transcription factor requirements for CIITA-
mediated activation are distinct from those of constitu-
tive transcription. Constitutive class I transcription, in
the absence of CIITA, depends upon the TAFII250 com-
ponent of the general transcription factor, TFIID. In the
temperature-sensitive TAFII250 mutant, tsBN462, con-
stitutive class I transcription is impaired at the restrictive
temperature where TAFII250 loses AT activity and is inac-
tive (Weissman et al., 1998; Dunphy et al., 2000). Surpris-
Figure 5. CIITA Activation Domain Deletions Fail to Rescue a ingly, CIITA-activated transcription does not require
TAFII250 Defect TAFII250, but does require functional AT activity. In addi-
(A and B) 2 mg of CIITA WT, mutants (closed bar) or control vector tion to the AT domain, the remaining CIITA activation
(open bar) were cotransfected with 5 mg 2416CAT class I reporter
domains are also necessary to effect promoter rescue.contruct in tsBN462 cells at 328C. After 24 hr cells were shifted to
However, the requirements are different in the presence398C or left at 328C for an additional 24 hr before harvesting and
and absence of TAFII250. Whereas the GTP-binding do-performing CAT assay. Data are expressed as percentage of acet-
ylation normalized to transfection control pSV2LUC. main is not necessary for activation in the presence of
functional TAFII250, it is necessary in the absence of
TAFII250. Thus, CIITA does not simply enhance constitu-acidic domain overlaps the CIITA AT domain described tive transcription, but appears to function through a
in the present study, which may account for its reported distinct transcriptional pathway.
activity. The mechanisms of action of the ProSerThr The role of TAFII250 in transcription initiation remains
domain and the C-terminal domain are not known. While to be fully elucidated. Although TAFII250 is clearly re-
the Pro subdomain may overlap the CIITA AT domain, quired for transcription of a large number of genes, nota-
the SerThr region is necessary for function, but not for bly those involved in cell cycle regulation, it is not re-
AT activity. Taken together, these data indicate that quired for many others in both yeast and mammalian
CIITA is a complex transactivator with multiple func- cells (Wang and Tjian, 1994; Suzuki-Yagawa et al., 1997;
tional domains, among which the AT domain plays a Wang et al., 1997; O’Brien and Tjian, 2000; Fondell et
critical role. al., 1999). The present findings with CIITA extend these
Class I promoter activation by CIITA requires both observations, by demonstrating that transcriptional acti-
downstream core promoter sequences and a CRE ele- vators can modulate a single promoter’s requirement
ment, located between 2100 and 2107 bp. Activation is for TAFII250 in vivo. Although similar observations have
augmented by a series of upstream sequence elements; been reported for viral transcription factors, such as the
deletion of the upstream modulators reduces the magni- SV40 Tag, HBV pX and HPV16E7 proteins (Sekiguchi et
tude of activation. We previously identified and charac- al., 1999), this is the first example of a cellular coactiva-
terized the class I CRE because it mediates TSH/cAMP- tor with AT activity able to bypass a promoter’s TAFII250
regulated repression of transcription (Saji et al., 1997; dependence in vivo.
Kirshner et al., 2000). Here, we demonstrate that deletion The present findings suggest CIITA has multiple func-
of the CRE element or the core promoter eliminates tions in transcriptional regulation. On one hand, it serves
CIITA-mediated activation. We further show that the as a nucleation site for the formation of a class II en-
class I CRE is sufficient to confer CIITA responsiveness hanceosome containing the class II X1, X2 and Y box
to a heterologous promoter. Previous studies described binding factors, providing a platform which integrates
upstream regulatory information with the basal tran-an upstream promoter sequence site-a (site-a corre-
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tants, and CIITA truncation mutant 1–148 have been described pre-scription machinery (Masternak et al., 2000). In this re-
viously (Chin et al., 1997). The CIITADC was generated by cloningspect, CIITA is similar to other coactivators. On the
the Kpn I fragment of Flag-CIITA WT into the Kpn I site of pcDNA3.other hand, unlike other coactivators which are ubiqui-
CIITADAT (D27–222) was generated by XcmI/Bsu36I digestion, re-
tously expressed and have extensive interactions with moving amino acids 27–222. The CBP ribozyme control and mutant
multiple transcription factors, CIITA is tissue specific plasmids have been described previously (Kawasaki et al., 1996;
Kawasaki et al., 1998). CIITA WT and mutant variants were clonedand interacts with those transcription factors limited
into the baculovirus transfer vector PVL1293 at the Eco RI site.largely to MHC class II transcription. CIITA also interacts
with a spectrum of basal transcription factors, including
Stable and Transient TransfectionsTAFII32, TAFII70, TFIIB, TBP (Mahanta et al., 1997; Scholl For stable transfection, L cells were cotransfected with 2 mg of
et al., 1997; Fontes et al., 1999). This suggests that its either CBP ribozyme or mutant CBP ribozyme plasmid and 200 ng
role in transcriptional regulation is distinct from pre- of tk1 plasmid and selected in HAT medium for 3 weeks. Transient
transfections were done by CaPO4 precipitation method, as de-viously described coactivators. Consistent with this hy-
scribed previously (Howcroft et al., 1995), with 5 mg of CAT reporterpothesis is the observation that CIITA does not depend
constructs and 2 mg of CIITA wild type mutants or control plasmid.on TAFII250.
tsBN462 cells were left at 328C for 24 hr after transfection and thenThe multifunctionality of CIITA is further evidenced by
shifted to 398C (restrictive temperature) or left at 328C (permissive
the differential requirement for CBP in CIITA-mediated temperature) for an additional 24 hr. HeLa cells and L cells were
activation of class I transcription compared with induc- maintained at 378C for 48 hr after transfection. Chloramphenicol
acetyltransferase (CAT) activity was normalized to luciferase activitytion of class II transcription. Whereas optimal activation
by cotransfecting an internal plasmid control pSV2LUC or RSV LUC.of the MHC class II promoter by CIITA requires the pres-
ence of CBP (Kretsovali et al., 1998; Fontes et al., 1999),
Immunoprecipitation and Western BlotCBP has no detectable effect on the ability of CIITA to
Cell lysates of HeLa, L or Sf9 cells transfected with 10 mg of Flag-
enhance class I promoter activity. The duality of CIITA CIITA WT or mutants were made in 2x PCV lysis buffer (50 mM Tris-
function has been proposed previously, based on the HCl [pH 8.0], 5 mM MgCl2, 150 mM KCl, 0.1% NP40, 10% glycerol
and protease inhibitors). The anti-Flag M2 agarose beads were acti-observation that CIITA is required both for assembling
vated according to the manufacturer’s protocol (Sigma). For immu-transcription factors on the class II promoter and for
noprecipitation, the cell lysate was incubated with the activated M2activation in interferon-inducible cells (Kara and Glim-
agarose beads at 48C overnight; protein was eluted with SDS samplecher, 1991; Wright et al., 1998; Villard et al., 1999; O’Brien
buffer. For immunoblotting, eluted protein was resolved on 10%
and Tjian, 2000). SDS-polyacrylamide gels and transferred to nitrocellulose. The pri-
The studies reported here suggest that activation of mary antibodies were mouse anti-Flag M2 antibody (10 mg/ml)
(Sigma) or rabbit anti-CBP (0.7 mg/ml) (Santa Cruz Biotechnology).the class I promoter involves CIITA-mediated triggering
Secondary antibodies were HRPO conjugated anti-mouse or anti-of the assembly of a novel array of transcription factors
rabbit antibodies. Proteins were detected by chemiluminescence(distinct from those constitutively assembled on the pro-
with SuperSignal substrate (Pierce).moter), which enables CIITA-mediated activation. We
propose the following model for CIITA activation of class Preparation of Recombinant Protein
I transcription. In the absence of CIITA, constitutive tran- Flag-CIITA WT or the mutants were expressed in Sf9 cells using
baculovirus-mediated transfection according to the manufacturer’sscription of class I requires functional TAFII250 in a TFIID
protocol (Pharmingen kit). Recombinant Flag-CIITA was immuno-complex. Nucleation of the TFIID complex on the core
precipitated using anti-Flag M2 agarose beads (Sigma) and elutedpromoter requires the presence of sequences that have
with 100 mg/ml of flag peptide.been mutated in the 2416M6 promoter construct, lead-
ing to its inactivity. In contrast, the preinitiation complex HAT Assay
(PIC) formed in the presence of CIITA no longer requires The HAT assay was a modification of a previously described proce-
dure (Mizzen et al., 1996). CIITA was incubated with 1 mg of H3 andTAFII250, but rather incorporates CIITA into a novel
H4 histones and 70 nCi of [3H]acetyl-CoA (10 Ci/pmol) and 15 nCiTFIID-like complex, which is likely to contain TAFII32.
of [14C]acetyl-CoA (60 mCi/pmol) in presence of 10 mM butyric acid,This pre-initiation complex does not require the M6 se-
50 mM Tris pH 8.0, 1 mM DTT, and 0.1 mM EDTA at 308C for 30quences, but, rather, is anchored by other core promoter
min. Where indicated, 1.25 mM GTP was included in the reaction
sequences. For this reason, CIITA is able to activate the mix. The reaction was stopped with SDS sample buffer and applied
promoter construct M6, which is inactive in its absence. to 16% SDS-polyacrylamide gels, which were fixed overnight; his-
tone acetylation was analyzed using Storm PhosphoImager with theUnlike TAFII250, CIITA also requires the presence of an
ImageQuant software.upstream CRE element to mediate activation. This
model suggests that the formation of a transcription
Received June 21, 2000; revised November 8, 2000.initiation complex on a given promoter is a dynamic
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